- Home
- NVNO vs LUCD Comparison
NVNO vs LUCD Comparison
Compare NVNO & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- LUCD
- Stock Information
- Founded
- NVNO 1987
- LUCD 2018
- Country
- NVNO United States
- LUCD United States
- Employees
- NVNO N/A
- LUCD N/A
- Industry
- NVNO Medical/Dental Instruments
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NVNO Health Care
- LUCD Health Care
- Exchange
- NVNO Nasdaq
- LUCD Nasdaq
- Market Cap
- NVNO 96.0M
- LUCD 112.5M
- IPO Year
- NVNO N/A
- LUCD 2021
- Fundamental
- Price
- NVNO $4.91
- LUCD $1.02
- Analyst Decision
- NVNO
- LUCD Strong Buy
- Analyst Count
- NVNO 0
- LUCD 4
- Target Price
- NVNO N/A
- LUCD $3.94
- AVG Volume (30 Days)
- NVNO 136.6K
- LUCD 704.2K
- Earning Date
- NVNO 07-31-2025
- LUCD 08-13-2025
- Dividend Yield
- NVNO N/A
- LUCD N/A
- EPS Growth
- NVNO N/A
- LUCD N/A
- EPS
- NVNO N/A
- LUCD N/A
- Revenue
- NVNO N/A
- LUCD $4,360,000.00
- Revenue This Year
- NVNO N/A
- LUCD $49.70
- Revenue Next Year
- NVNO N/A
- LUCD $198.20
- P/E Ratio
- NVNO N/A
- LUCD N/A
- Revenue Growth
- NVNO N/A
- LUCD 14.74
- 52 Week Low
- NVNO $2.03
- LUCD $0.73
- 52 Week High
- NVNO $5.70
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- NVNO 56.87
- LUCD 44.17
- Support Level
- NVNO $4.33
- LUCD $0.96
- Resistance Level
- NVNO $5.13
- LUCD $1.03
- Average True Range (ATR)
- NVNO 0.35
- LUCD 0.06
- MACD
- NVNO -0.05
- LUCD 0.00
- Stochastic Oscillator
- NVNO 62.50
- LUCD 43.75
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.